terazosin
A quinazoline derivative which is an alpha-1-selective adrenoceptor blocking agent used on once-a-day basis for therapy of mild-to-moderate hypertension. Terazosin is indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH). Reference standards of Terazosin API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Terazosin Hydrochloride (1643452)
[catalogue_number] => PA USP1643452
[category_ids] => ,149,
[chemical_name] =>
[weight] => NA
[form] =>
[cas] => 70024-40-7
[pslug] => 70024-40-7-terazosin-hydrochloride-1643452-pausp1643452
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Terazosin Hydrochloride (1643452)
stdClass Object
(
[pname] => Terazosin Related Compound A (1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)piperazine dihydrochloride) (1643463)
[catalogue_number] => PA USP1643463
[category_ids] => ,149,
[chemical_name] =>
[weight] => NA
[form] =>
[cas] => NA
[pslug] => terazosin-related-compound-a-1-4-amino-6-7-dimethoxy-2-quinazolinyl-piperazine-dihydrochloride-1643463-pausp1643463
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Terazosin Related Compound A (1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)piperazine dihydrochloride) (1643463)
stdClass Object
(
[pname] => Terazosin Related Compound B (1-(4-hydroxy-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)c (1643474)
[catalogue_number] => PA USP1643474
[category_ids] => ,149,
[chemical_name] =>
[weight] => NA
[form] =>
[cas] => NA
[pslug] => terazosin-related-compound-b-1-4-hydroxy-6-7-dimethoxy-2-quinazolinyl-4-tetrahydro-2-furanyl-c-1643474-pausp1643474
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Terazosin Related Compound B (1-(4-hydroxy-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)c (1643474)
stdClass Object
(
[pname] => Terazosin Related Compound C (1,4-bis(4-amino-6,7-dimethoxy-2-quinazolinyl)piperazine dihydrochlori (1643485)
[catalogue_number] => PA USP1643485
[category_ids] => ,149,
[chemical_name] =>
[weight] => NA
[form] =>
[cas] => NA
[pslug] => terazosin-related-compound-c-1-4-bis-4-amino-6-7-dimethoxy-2-quinazolinyl-piperazine-dihydrochlori-1643485-pausp1643485
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Terazosin Related Compound C (1,4-bis(4-amino-6,7-dimethoxy-2-quinazolinyl)piperazine dihydrochlori (1643485)
